Allakos Inc. (ALLK)
NASDAQ: ALLK · Real-Time Price · USD
0.286
-0.005 (-1.72%)
At close: Feb 21, 2025, 4:00 PM
0.282
-0.004 (-1.44%)
After-hours: Feb 21, 2025, 7:58 PM EST
Allakos Employees
Allakos had 131 employees as of December 31, 2023. The number of employees increased by 8 or 6.50% compared to the previous year.
Employees
131
Change (1Y)
8
Growth (1Y)
6.50%
Revenue / Employee
n/a
Profits / Employee
-$1,364,466
Market Cap
25.53M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ALLK News
- 11 days ago - Lycia Therapeutics Announces the Appointment of Chin Lee, MD, MPH, as Chief Medical Officer and Reveals Immunology Pipeline - GlobeNewsWire
- 12 days ago - Kuehn Law Encourages Investors of Allakos Inc. to Contact Law Firm - GlobeNewsWire
- 26 days ago - Why Is Allakos Stock Plunging On Monday? - Benzinga
- 26 days ago - Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring - GlobeNewsWire
- 3 months ago - Allakos Runs Up Into A Near-Term Catalyst - Seeking Alpha
- 3 months ago - Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers - GlobeNewsWire
- 7 months ago - Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results - GlobeNewsWire